BillionToOne launches Northstar Origin liquid biopsy to predict where an unknown cancer began
BillionToOne has launched Northstar Origin, a laboratory-developed liquid biopsy add-on that combines cfDNA methylation and genomic signals to predict tumor tissue of origin from one blood sample.